	Acupuncture for cancer-related fatigue in breast cancer survivors: the AcuBreast study, a pragmatic randomized clinical trial. Integr Med Res Alræk T, Skjerve H, Sørensen A, Mao JJ, Lamu AN, Lu W, Deng G, Lee MS, Birch S, Kim TH, Lie SA. PMID: 43034755 [PubMed]
	Burden and Temporal Trends of Female Breast Cancer Attributable to High Fasting Plasma Glucose in China and G20 Countries, 1990-2023: An Analysis of the Global Burden of Disease Study 2023. Int J Womens Health Zheng J, Ye Z, Chen S, Lin W, Chen W, Li H, Kuang Z, Wu X. PMID: 43034638 [PubMed]
	Co-conditioning and parallel cell homing-driven pre-metastatic niche engineering: TGF-Î²-fuelled 3D microphysiological model for epithelial-mesenchymal transition in breast cancer. In Vitro Model Vaishnavi M, Kumari M, Pal S, Kaur K, Kaity S, Mandal C, Roy S. PMID: 43034390 [PubMed]
	Impact of Lifestyle Behaviors and Social Determinants of Health on Breast Cancer Prevention and Survivorship: A Comprehensive Primary Analysis of Patient-Reported Data. Am J Lifestyle Med Ayers KE, Mussallem D, Petrov JC, Pedersen L. PMID: 43034359 [PubMed - as supplied by publisher]
	Weight-Adjusted Waist Index and Breast Cancer Prevalence in U.S. Adult Women: A Cross-Sectional NHANES Analysis (1999-2016). Cancer Med Li Y, Yang Z, An Y, Yu Y, Cao X, Wang X. PMID: 43034091 [PubMed - indexed for MEDLINE]
	Determinants of participation in organized breast, cervical and colorectal cancer screening in Europe: A scoping review. Health Policy Marasciulo D, Mercuri C, Simeone S, Doldo P. PMID: 43033790 [PubMed - as supplied by publisher]
	Collagen and CXCL10 expression as key components of the structural and inflammatory dimensions of the tumor microenvironment in breast cancer subtypes. Acta Histochem Nakano LKM, Moreira TB, Pereira RA, Mesquita FAS, Teixeira-Carvalho A, Salles PGO, Portella MAM, Amorim IFG, Braga LDC. PMID: 43033750 [PubMed - as supplied by publisher]
	Pregnancy after breast cancer and risk of recurrence. A risk-set-matched cohort study with a time-dependent analysis. Cancer Epidemiol Bonyadi M, Hosseinpour Z, Akbari A, Akbari ME. PMID: 43033674 [PubMed - as supplied by publisher]
	Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE). Breast Ozaki Y, Taniguchi E, Nozawa K, Niwa Y, Hara F, Nonogaki K, Kuno M, Aoyama Y, Inagaki L, Masuda J, Nishimura M, Kurata M, Hosonaga M, Fukada I, Kimura Y, Maeda T, Yoshida K, Yamashita N, Kobayashi T, Takano T, Ueno T. PMID: 43033562 [PubMed - as supplied by publisher]
	Updated results from ASCENT-J02, a study of sacituzumab govitecan in Japanese participants with metastatic triple-negative breast cancer. Int J Clin Oncol Kawaguchi-Sakita N, Naito Y, Ishida T, Nakayama T, Yamamoto Y, Masuda N, Matsumoto K, Kogawa T, Sudo K, Shimomura A, Lai C, Shao J, Iwahori Y, Gary D, Huynh D, Iwata H. PMID: 43033364 [PubMed - as supplied by publisher]
	Screening for rehabilitation needs in newly diagnosed breast cancer patients: exploring psychometric properties of the National Comprehensive Cancer Network(Â®) (NCCN(Â®)) Distress Thermometer and Problem List. J Patient Rep Outcomes Velickovic K, Bendahl PO, Olsson Möller U, Rydén L, Malmström M. PMID: 43033328 [PubMed - indexed for MEDLINE]
	Rechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors. Breast Cancer Res Treat Petrelli F, Ghidini A, Parati MC, Ghilardi M, Borgonovo K, Dottorini L. PMID: 43033310 [PubMed - indexed for MEDLINE]
	Association between screen-detected health-related social needs and nonadherence to endocrine therapy in patients with nonmetastatic breast cancer: an observational study. Breast Cancer Res Treat Liyanage-Don N, DeStephano D, Sathe C, Lee S, Beauchemin M, Accordino M, Hershman D, Kronish IM. PMID: 43033306 [PubMed - indexed for MEDLINE]
	Survival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis. Breast Cancer Res Treat Wu Y, Kong L, Oghenefejiro EE, Cao X, Wang D, Tao C, Wang X, Qin R, Ji Y, Yin L. PMID: 43033282 [PubMed - indexed for MEDLINE]
	Changes in functional capacity, flexibility and depressive symptoms in women with breast cancer submitted to adjuvant radiotherapy: randomized controlled clinical trial with mat pilates. Support Care Cancer Torres DM, de Menezes Fireman K, Fabro EAN, Thuler LCS, Bergmann A, da Silva Santos S. PMID: 43033270 [PubMed - indexed for MEDLINE]
	Cardiac substructure dose in thoracic VMAT without explicit constraints: FMO versus SPO on uRT-TPOIS with cross-platform reference to eclipse PO. J Appl Clin Med Phys Wu C, Cao Z, Duan T, Han L, Wang B, Lei W. PMID: 43033214 [PubMed - indexed for MEDLINE]
	Survival Differences Between De Novo and Recurrent HER2-Positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. Oncology Komatsu T, Osawa H, Cronin K, Okazawa K, Suzuki T, Tiersten A. PMID: 43033143 [PubMed - as supplied by publisher]
	CRISPR-AsCas12a with crRNA-Free Collateral Cleavage Activity for Electrochemical Diagnosis of HER2-Positive Breast Cancer. ACS Sens Wu S, Xu J, Sun Y, Zeng T, Li Z, Zhou T, Deng Y, Ye C, Li G, Yin Y. PMID: 43033087 [PubMed - as supplied by publisher]
	Cross-ancestry proteome-wide mendelian randomization of plasma proteins and breast cancer susceptibility. J Natl Cancer Inst Wu X, Godbole D, Williams J, Sharma J, Choi J, Liu Z, Kraft P, Zhang H. PMID: 43033043 [PubMed - as supplied by publisher]
	Pre-Radiotherapy Risk Prediction of Grade â‰¥2 Radiotherapy-Induced Lymphopenia in Breast Cancer: A Single-Center Interpretable Machine Learning Study. Int J Gen Med Ding L, Qiu H, Wang M, Lu Y, Huang T, Wang Y, Shi Q, Shen K. PMID: 43032615 [PubMed]

Articles 1 - 20 / 338146

Page 1 of 16908



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy